Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Top 12 High Conviction Stocks Picks For April 2015 By Edelweiss



Edelweiss has issued a report of its twelve high conviction stock picks for April 2015 with the potential for market beating returns




Edelweiss Top Picks are high conviction stocks which have the potential to generate market-beating returns over the next 12-18 months. Edelweiss Top Picks have delivered a CAGR return of 41% since inception as against Nifty CAGR return of 16%, translating into an outperformance of 25% (p.a). On an annualized basis, Top Picks have delivered a return of 68% per annum as against Nifty return of 26%. The Top Picks portfolio is suitable for investors looking to invest for the next 12-18 months.

Click here to download Edelweiss high conviction picks for April 2015
investments, Mid Cap, Multibagger, Portfolio, Top Picks    , , ,

No Comments Yet

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap)
    Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap) for Nov '24. The Basket has delivered return of 329% since inception (May’20) vs 162% return delivered by NIFTY Index over the same period due to thematic approach to Top Picks selection Download report
  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!